← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vm Discovery, Inc.
Fremont, CA
$2,330,544
Total funding
3
Grants
Funding over time
peak $498.3K · FY2007–13$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,330,544 · 3
By mechanism
R44$2,034,167 · 1
N43$198,224 · 1
R43$98,153 · 1
Investigators at Vm Discovery, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism$498,258
R44 · FY2007 · AA
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism$498,060
R44 · FY2008 · AA
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism$473,919
R44 · FY2012 · AA
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism$463,933
R44 · FY2013 · AA
TAS::75 0849::TAS DEVELOPMENT OF ANTI-CANCER AGENTS.$198,224
N43 · FY2010 · CA
Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism$99,997
R44 · FY2009 · AA
Multi-Property Design Selective PKC_epsilon Inhibitors$98,153
R43 · FY2004 · AA